| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |